News
The researchers are working on three future projects using their model, including using induced pluripotent stem cells from a ...
Per- and polyfluoroalkyl substances (PFAS), manmade chemicals that accumulate in the body over time, have been linked to liver disease and cancer, but it is not yet clear how they cause damage.
Scientists have achieved a major breakthrough by 3D bioprinting miniature placentas, providing a new way to study pregnancy complications.
Per- and polyfluoroalkyl substances (PFAS), manmade chemicals that accumulate in the body over time, have been linked to liver disease and cancer, but it is not yet clear how they cause damage. USC ...
ZME Science on MSN
Researchers Transformed Sperm Cells into Tiny, Microbots That Could Deliver Drugs to Hard-to-Reach Places
Delivering therapies precisely without affecting nearby healthy tissues is one of the most pressing fields of research in ...
AZoLifeSciences on MSN
Human-Derived 3D Skin Model May Replace Animals In Wound Studies
Engineered 3D skin model successfully simulates early wound healing, offering insights into inflammatory responses and potential therapeutic applications.
Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...
How do cells know what they should become as the body develops? Biological development depends crucially on spatial patterns: ...
Scientists grew organoids, or tiny models of the brain ... organoid — a miniature 3D structure, grown from stem cells, that mimics a full-size structure found in the human body. Prior to the organoid ...
Interesting Engineering on MSN
World-first 3D placentas print early tissue, test drugs, and reveal pregnancy risks
This breakthrough combines 3D bioprinting, organoid technology, and placental research. It may pave the way for safer drugs, ...
Modern imaging is contributing significantly to giving us a better understanding of how our brains work. In the long term, this will also help us to treat learning disorders in a more targeted way and ...
Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results